Edition:
United States

Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

9.00USD
4:00pm EDT
Change (% chg)

$0.50 (+5.88%)
Prev Close
$8.50
Open
$8.55
Day's High
$9.30
Day's Low
$8.55
Volume
113,259
Avg. Vol
86,758
52-wk High
$15.95
52-wk Low
$6.35

Chart for

About

Cytokinetics, Incorporated is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. It is focused on the discovery and development... (more)

Overall

Beta: 1.44
Market Cap(Mil.): $464.34
Shares Outstanding(Mil.): 54.63
Dividend: --
Yield (%): --

Financials

  CYTK.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -2.50 -- --
ROI: -49.34 1.50 12.72
ROE: -104.45 0.19 14.85

BRIEF-Cytokinetics And Cure SMA Renew And Expand Partnership To Advance Education And Awareness Of SMA

* CYTOKINETICS AND CURE SMA RENEW AND EXPAND PARTNERSHIP TO ADVANCE EDUCATION AND AWARENESS OF SMA

May 17 2018

BRIEF-Cytokinetics Reports Q1 Loss Per Share Of $0.56

* CYTOKINETICS, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

Apr 26 2018

Earnings vs. Estimates